I 

116TH CONGRESS 

2D SESSION H. R. 7627 

To promote affordable access to evidence-based opioid treatments under the 

Medicare program and require coverage of medication assisted treatment 

for opioid use disorders, opioid overdose reversal medications, and recovery support services by health plans without cost-sharing requirements. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 16, 2020 

Ms. DEAN introduced the following bill; which was referred to the Committee 

on Energy and Commerce, and in addition to the Committee on Ways 

and Means, for a period to be subsequently determined by the Speaker, 

in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To promote affordable access to evidence-based opioid treatments under the Medicare program and require coverage 

of medication assisted treatment for opioid use disorders, 

opioid overdose reversal medications, and recovery support services by health plans without cost-sharing requirements. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


kjohnson on DSK79L0C42PROD with BILLS
2 

•HR 7627 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Maximizing Opioid Re3 covery Emergency Savings Act’’ or the ‘‘MORE Savings 

4 Act’’. 

5 SEC. 2. TESTING OF ELIMINATION OF MEDICARE COST6 SHARING FOR EVIDENCE-BASED OPIOID 

7 TREATMENTS. 

8 Section 1115A(b)(2) of the Social Security Act (42 

9 U.S.C. 1315a(b)(2)) is amended— 

10 (1) in subparagraph (A), in the last sentence, 

11 by inserting ‘‘, and shall include the model described 

12 in subparagraph (D) (which shall be implemented by 

13 not later than six months after the date of the en14 actment of the Maximizing Opioid Recovery Emer15 gency Savings Act)’’ before the period at the end; 

16 and 

17 (2) by adding at the end the following new sub18 paragraph: 

19 ‘‘(D) AFFORDABLE ACCESS TO EVIDENCE20 BASED OPIOID TREATMENTS.— 

21 ‘‘(i) IN GENERAL.—The model de22 scribed in this subparagraph is a model 

23 that seeks to provide affordable access to 

24 evidence-based opioid treatments and re25 covery support services by eliminating coin26 surance, copayments, and deductibles othVerDate Sep 11 2014 05:36 Aug 05, 2020 Jkt 099200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H7627.IH H7627

kjohnson on DSK79L0C42PROD with BILLS
3 

•HR 7627 IH

1 erwise applicable under parts B and D of 

2 title XVIII (including as such parts are ap3 plied under part C of such title) for the 

4 following items and services that are other5 wise covered under such parts: 

6 ‘‘(I) Drugs and biologicals pre7 scribed or furnished to treat opioid 

8 use disorders or reverse overdose. 

9 ‘‘(II) Behavioral health services 

10 furnished for the treatment of opioid 

11 use disorders. 

12 ‘‘(III) Recovery support services 

13 to maintain a healthy lifestyle fol14 lowing opioid misuse treatment, such 

15 as peer counseling and transportation. 

16 ‘‘(ii) SELECTION OF SITES.—The CMI 

17 shall select 15 States in which to conduct 

18 the model under this subparagraph. A 

19 State shall meet each of the following cri20 teria in order to be selected under the pre21 ceding sentence: 

22 ‘‘(I) The State has a high pro23 portion of Medicare beneficiaries. 

24 ‘‘(II) The State has a high rate 

25 of overdose deaths due to opioids. 


kjohnson on DSK79L0C42PROD with BILLS
4 

•HR 7627 IH

1 ‘‘(III) The State has a significant 

2 percentage of rural areas. 

3 ‘‘(iii) TERMINATION AND MODIFICA4 TION PROVISION NOT APPLICABLE FOR

5 FIRST FIVE YEARS OF THE MODEL.—The 

6 provisions of paragraph (3)(B) shall apply 

7 to the model under this subparagraph be8 ginning on the date that is five years after 

9 such model is implemented, but shall not 

10 apply to such model prior to such date.’’. 

11 SEC. 3. COVERAGE OF OPIOID TREATMENTS. 

12 Title XXVII of the Public Health Service Act is 

13 amended by inserting after section 2719A (42 U.S.C. 

14 300gg–19a) the following: 

15 ‘‘SEC. 2720. COVERAGE OF OPIOID TREATMENTS. 

16 ‘‘A group health plan and a health insurance issuer 

17 offering group or individual health insurance coverage 

18 shall, at a minimum, provide coverage for and shall not 

19 impose any cost-sharing requirements for— 

20 ‘‘(1) prescription drugs for the treatment of 

21 opioid use disorders or to reverse overdose; 

22 ‘‘(2) behavioral health services for the treat23 ment of opioid use disorders; or 

24 ‘‘(3) recovery support services that are provided 

25 in conjunction with medication-assisted treatment 


kjohnson on DSK79L0C42PROD with BILLS
5 

•HR 7627 IH

1 for an opioid use disorder, such as peer counseling 

2 and transportation, to support the enrollee in main3 taining a healthy lifestyle following opioid misuse 

4 treatment.’’. 

5 SEC. 4. ENHANCED FEDERAL MATCH FOR MEDICATION-AS6 SISTED TREATMENT AND RECOVERY SUP7 PORT SERVICES UNDER MEDICAID. 

8 (a) IN GENERAL.—Section 1905(b) of the Social Se9 curity Act (42 U.S.C. 1396d(b)) is amended by adding 

10 at the end the following: ‘‘Notwithstanding the first sen11 tence of this subsection, the Federal medical assistance 

12 percentage shall be 90 percent with respect to amounts 

13 expended during the period described in subsection (a)(29) 

14 by a State that is one of the 50 States or the District 

15 of Columbia as medical assistance for medication-assisted 

16 treatment (as defined in subsection (ee)(1)).’’. 

17 (b) STATE OPTION TO PROVIDE RECOVERY SUP18 PORT SERVICES AS PART OF MEDICATION-ASSISTED

19 TREATMENT.—Section 1905(ee)(1) of the Social Security 

20 Act (42 U.S.C. 1396d(ee)(1)) is amended— 

21 (1) in subparagraph (A), by striking ‘‘; and’’ 

22 and inserting a semicolon; 

23 (2) in subparagraph (B), by striking the period 

24 at the end and inserting ‘‘; and’’; and 


kjohnson on DSK79L0C42PROD with BILLS
6 

•HR 7627 IH

1 (3) by adding at the end the following new sub2 paragraph: 

3 ‘‘(C) at the option of a State, includes re4 covery support services, such as peer counseling 

5 and transportation, that are provided to an in6 dividual in conjunction with the provision of 

7 such drugs and biological products to support 

8 the individual in maintaining a healthy lifestyle 

9 following opioid misuse treatment.’’. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS